Minimum Dose CT Post Lung Biopsy
Phase 1
Completed
- Conditions
- Lung Cancer
- Registration Number
- NCT00188162
- Lead Sponsor
- University Health Network, Toronto
- Brief Summary
The aim is to evaluate whether Minimum Dose CT (MnDCT) is useful in the management of patients post Lung Biopsy
- Detailed Description
Patients post Lung Biopsy have a chest X-ray (CXR) and a MnDCT post lung biopsy. Both studies are compared for the detection of a pneumothorax
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- All Patients having a lung biopsy
Read More
Exclusion Criteria
- None
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Detection of Pneumothorax
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Toronto General Hospital
🇨🇦Toronto, Ontario, Canada